Sterling Investment Advisors (Pennsylvania)’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-7
Closed 482
2022
Q2
$0 Hold
7
﹤0.01% 625
2022
Q1
$1K Hold
7
﹤0.01% 569
2021
Q4
$1K Hold
7
﹤0.01% 554
2021
Q3
$1K Hold
7
﹤0.01% 557
2021
Q2
$1K Hold
7
﹤0.01% 523
2021
Q1
$1K Hold
7
﹤0.01% 498
2020
Q4
$1K Hold
7
﹤0.01% 439
2020
Q3
$1K Hold
7
﹤0.01% 423
2020
Q2
$0 Hold
7
﹤0.01% 445
2020
Q1
$0 Buy
+7
New +$490 ﹤0.01% 441

Other funds holding TNDM

Sterling Investment Advisors (Pennsylvania)'s TNDM Position: Q3 2022 in Review

Sterling Investment Advisors (Pennsylvania) sold out of Tandem Diabetes Care (TNDM) in Q3 2022, closing a stake of 7 shares.

Sterling Investment Advisors (Pennsylvania) first reported a position in TNDM in Q1 2020 and held it in 10 quarters. The position peaked at $1K in Q1 2022. 299 funds tracked by Wall St. Rank hold TNDM as of Q3 2022.

  • Sterling Investment Advisors (Pennsylvania) reported no remaining Tandem Diabetes Care position as of Q3 2022 after selling out during the quarter.
  • Sterling Investment Advisors (Pennsylvania) sold 7 Tandem Diabetes Care shares in Q3 2022.
  • Sterling Investment Advisors (Pennsylvania) first reported a position in Tandem Diabetes Care in Q1 2020 and held it in 10 quarters.
  • Sterling Investment Advisors (Pennsylvania)'s Tandem Diabetes Care position peaked at $1K in Q1 2022.
  • 299 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2022.

Based on Sterling Investment Advisors (Pennsylvania)'s 13F filing for Q3 2022, filed 3 Nov 2022.